Corcept Therapeutics Inc.
N/A
USD
N/A
N/A
...
Chart
Financials
Description
CORT Company Description
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.
CORT Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view CORT Smart Score
Score Breakdown
CORT Company Description
Show More
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of CORT by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CORT's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on CORT's company Twitter account
WallStreetBets
Number of mentions of CORT in WallStreetBets Daily Discussion
CORT News
Recent insights relating to CORT
CNBC Recommendations
Recent picks made for CORT stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in CORT
Corporate Flights
Flights by private jets registered to CORT
Our Analysis